Prot #BL-8040.01: A Phase IIa, Multicenter, Open-Label Study Designed to Evaluate the Safety and Efficacy of Escalating Doses of BL-8040 in Adult Subjects with Relapsed/Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date7/28/13 → 7/28/15

Funding

  • BioLineRx Ltd. (Prot #BL-8040.01)